EPIC is pleased to announce Landon J. Getz as the recipient of the inaugural GSK EPIC Convergence Fellowship in Antimicrobial Resistance (AMR). Established through a generous gift from GlaxoSmithKline (GSK), the fellowship will support Getz’s innovative and cross-disciplinary research that aims to address the growing threat of AMR through the development of phage therapy.
The Emerging and Pandemic Infections Consortium (EPIC) has announced the four recipients of the 2023 Inspire Summer Studentships. These studentships aim to foster inclusive excellence by providing third-year Black and Indigenous undergraduate students with opportunities to engage in infectious disease research with and receive mentorship from EPIC’s faculty members. Each award provides $7,500 to support the student for a 16-week work term.
The Emerging and Pandemic Infections Consortium (EPIC) has announced its inaugural cohort of Doctoral Awards recipients. These 31 PhD students are engaged in innovative and collaborative research on infectious diseases. Their work spans from fundamental research uncovering the inner workings of microbes and their interactions with hosts, to applied research focused on improving diagnostics and vaccines, to community-based research on the social and economic impacts of infectious diseases.
A new national hub focused on enhancing Canada’s ability to respond quickly, effectively and equitably to future pandemics has become a reality with $2 million in funding from the Canada Biomedical Research Fund. Led and anchored by the University of Toronto, the Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI3) is a collaborative, multi-disciplinary and multi-sector coalition of over 80 partners. It will provide a powerful network to support a robust domestic pipeline of life-saving vaccines and therapeutics targeting existing and emerging infectious threats.
The University of Toronto has received $35 million in critical research infrastructure funding from the federal government to revitalize the Toronto High Containment Facility (THCF), an investment that will support a planned $85-million transformation of the facility into the largest academic high-containment research centre in Canada. With significantly increased capacity for research and training, the revitalized Toronto High Containment Facility will be able to drive innovation, enhance pandemic preparedness and strengthen Ontario and Canada’s health security.
July 6, 2022 By Betty Zou The University of Toronto and its partner hospitals, including Sunnybrook Research Institute, Unity Health Toronto and the University Health Network, are leading a rapid research response to the global monkeypox outbreak, to better...
Related page →
Link to resource →
Contact us CTA →